Klazien Matter-Walstra

20. September 2015

New publication

A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-positive melanoma in the Swiss setting.

Matter-Walstra K, Braun R, Kolb C, Ademi Z, Dummer R, Pestalozzi BC, Schwenkglenks M.

Br J Dermatol. 2015 Sep 2. doi: 10.1111/bjd.14152. [Epub ahead of print]

Tags: Arbeit

Kommentar schreiben

Kommentare: 0

Sa

27

Jan

2024

Publication

Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis.

Daniel Krüerke , Marianne Schenker, Klazien Matter-Walstra

Sa

27

Jan

2024

Croatia-Montenegro sailing

Sa

27

Jan

2024

Newest Art

See some of my newest works

Mi

10

Mai

2023

Croatia Mai-June 2023

Sailing in Croatia Mai-June 2023

Di

11

Okt

2022

Croatia 2022

Fr

18

Jun

2021

Sailing 2021

Sailing trip Italy Greece

mehr lesen